Newsletter | May 15, 2025

05.15.25 -- Optimize mAb Success: CDC Assays, Glycan Profiling, And ADC QC Strategies

Why Cell Line Screening Is Crucial For Successful CDC Assay Development

When developing a CDC assay for mAb characterization or QC testing, it's critical to select a target cell line that expresses the mAb ligand and consider CRP expression on the cell surface.

 

Stability Screening Using DLS And Thermal Shift Assays

Colloidal stability is one of the most important properties to control due to the propensity for biopharmaceuticals to aggregate and the subsequent potential to severely affect the drug's efficacy and patient safety.

 

Characterizing The Effector Functions Of Therapeutic Antibodies

Gain a thorough understanding of the Fc region of your antibody product and how to use a risk-based approach to strategically test its functionality, optimize safety, efficacy, and development.

 

N-Glycan Characterization With LC-MS

Glycosylation, a prevalent modification of mAbs, significantly impacts their function. Delve into various techniques for analyzing released glycans and their relative efficacy in HILIC-FLR-MS.

 

SOLUTIONS

ADCs: Analytical Considerations For QC Release, Stability Testing, Characterization, Comparability

Develop a robust analytical strategy to ensure the quality and consistency of your antibody-drug conjugate by evaluating each component and navigating multi-site manufacturing complexities.

• Request Information